Entries by MGluckle@MedicalAffairs.org

Unlocking the Potential of a Medical Affairs Budget

/in , , , , , , , , , /by

Unlocking the Potential of a Medical Affairs Budget

Objectives:

A webinar featuring expert speakers focusing on how to unlock the potential of a Medical Affairs budget, including how to prioritize and how to create once, but publish many’ to maximize the impact of engagements.

This webinar aims to discuss and address the following questions:

  1. When creating strategic and tactical plans – what are the most effective ways to prioritise planned Medical Affairs activities versus a limited and scrutinised budget
  2. What are the most important measures of value for initiatives and activities in the Medical Affairs space – how can one best gauge and communicate the likely value of planned activities
  3. When delivering Medical Affairs initiatives and activities what are the industry best practices / innovations that allow maximum value and impact for the most cost-effective budget

Access Options

Delivering an Effective Data Dissemination Strategy in a Transforming Industry

/in , , , , , , , , , /by

Delivering an Effective Data Dissemination Strategy in a Transforming Industry

Objectives:

We live in an extraordinary time. A time of continued change and innovation for society, our industry and for medical communications.

Data dissemination is key in the journey of Medical Affairs, but the fabric of data dissemination is transforming in its science and data, audiences, HCP preferences and demands as well as in technology and channels of communications.

While data generation is imperative, a misaligned data dissemination strategy will only result in data not reaching its full potential.

So, how are medical communicators embracing the transformations in data dissemination?

This webinar, with expert insight and examples from industry, explores how pharma is embracing these changes in practice.

By the end of this panel discussion, participants will:

  1. Comprehend the key areas of transformation impacting medical communications and data dissemination.
  2. Gain insights into how pharma is planning for and best practices in embracing these key transformational trends, supported by expert observations and real-world case examples

Access Options

Innovative Roles Between Medical and Commercial – Where Should the Limit Be?

/in , , , , , , , , , /by

Innovative Roles Between Medical and Commercial - Where Should the Limit Be?

Objectives:

This webinar aims to explore and provide a nuanced understanding of Innovative Medical Affairs roles within the pharmaceutical industry for critical evaluation by the Medical Affairs community, including new “Hybrid Medical Science Liaison (MSL)” roles ranging from business savvy to more commercially aware MSLs.

Experienced industry representatives will engage in a thoughtful examination of the origins of new structures and roles and their varying potential interpretations. Drawing from real-world examples, they will illustrate the practical implications within their respective companies. The central theme of this discussion revolves around striking a balance between scientific objectivity and commercial awareness, while also addressing the ethical and compliance considerations associated with the role.

The goal of this webinar is to provide a platform for meaningful discourse. By discussing the Hybrid MSL role, our objective is to encourage best practices and start developing a consensus on the associated opportunities and limitations of the role.

This webinar will:

  1. Provide participants with a comprehensive understanding of the hybrid MSL role and its diverse interpretations within the pharmaceutical industry.
  2. Offer real-world examples and case studies from experienced pharmaceutical professionals, allowing attendees to glean practical insights.
  3. Foster a heightened awareness of the ethical and compliance considerations inherent to the hybrid MSL role.
  4. Initiate collaboration: Encourage open dialogue and critical thinking within the Medical Affairs community, to work toward a consensus on the evolving scope and potential best practices for the hybrid MSL role.

Access Options

Building Medical Affairs as a Strategic Partner in Clinical Development

/in , , , , , , , , , , , /by

Building Medical Affairs as a Strategic Partner in Clinical Development

Objectives:

Medical Affairs teams are uniquely positioned to be the ‘strategic conveners’ of all stakeholders to help strategically guide the clinical development pathway from trial conception through pre-commercialization preparation.

By the end of this webinar, attendees will learn...

  1. The benefits of early Medical Engagement in the trial design process, including protocol development, patient voice (e.g., advocacy engagement, patient ad boards, DE&I), and site selection
  2. How Medical Affairs teams can help to accelerate study execution via Clinical Trial Liaisons, Research Science Liaisons, and investigator and patient engagement
  3. The role of Medical Affairs in translating clinical insights/relationships into value for Commercial teams via pre-commercialization strategies and market preparation

This webinar will provide the Medical Affairs community with a differentiated and bold view to drive the future state of Medical Affairs and what “good” looks like regarding the role of Medical Affairs in Clinical Development.

Access Options

Medical Affairs Mastery: Shaping the Future of MedTech with MAPS

/in , , , , , , , , , , , /by

Medical Affairs Mastery: Shaping the Future of MedTech with MAPS

Objectives:

Join the MAPS Med Tech FAWG as they discuss "Medical Affairs Mastery: Shaping the Future of MedTech with MAPS"!

This webinar will help attendees:

  1. Develop an understanding of MedTech, a diverse and innovative field, within the broader life sciences landscape and discuss how it has evolved in recent years
  2. Understand the emerging role of Medical Affairs within MedTech across the 4 key pillars: evidence generation, scientific communication, insights, and strategy
  3. See the value that the Medical Affairs Professional Society plays in supporting the development of Medical Affairs within MedTech by providing education, building professional community, and establishing best practices for our new and growing field.

Access Options

Essential Elements of a “Best-in-Class” Medical Information Organization

/in , , , , , , , , , , , , /by

In this webinar, our panelists highlight key areas of the Standards and Guidance created between MAPS, phactMI & MILE and how to use this S&G to move to a best-in-class medical information organization.

Patient Centricity in Medical Affairs: Identifying and Overcoming Barriers

/in , , , , , , , , , , , /by

Patient Centricity in Medical Affairs: Identifying and Overcoming Barriers

Objectives:

The MAPS Patient Centricity FAWG surveyed Medical Affairs community, including MAPS members, for their input on patient centricity initiatives within their respective organizations.  We will be sharing insights from the recent MAPS Patient Centricity Survey on industry perspectives, including the major barriers to implementing initiatives that were identified in the survey.  Our experts will be providing guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through the survey.

Access Options

Charting a Course to Excellence: Discovering the Latest in Medical Publication Guidelines

/in , , , , , , , , , , , /by

Charting a Course to Excellence: Discovering the Latest in Medical Publication Guidelines

Objectives:

Medical Affairs professionals engage with a broad array of medical communications, including peer-reviewed publications of company-sponsored research. Recent updates to Good Publication Practice and by the International Committee of Medical Journal Editor’s Recommendations present guidance on emerging topics such as plain language summaries (PLS), social media, enhanced publication content, artificial intelligence, authorship, and inclusivity. New focus areas include the roles of enhanced content and the need for equity among all stakeholders, including patients. GPP 2022 was also reimagined to serve as an introduction to the field.

Expert viewpoints inclusive of industry, agencies, academia, and publishers will provide a holistic overview of the implications of these updates for Medical Affairs professionals. The presenters will provide their perspectives on topics for which we are all seeking answers, including considerations for patient authorship and enhanced publication content, the use of generative AI in content development, and how social media and third party channels might interact in the medical communications space.

This webinar is suitable for Medical Affairs professionals, medical communications professionals from industry and agencies, researchers and other publication authors, and medical writers and editors.

The Educational Objectives of this webinar are...

  1. To ensure awareness of the most recent guidance updates affecting biomedical publications
  2. To discuss the impact of these updates on professional practice
  3. To provide insights on application of principles from guidance updates for emerging topics

Access Options

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS event and resource updates
MAPS Program Support Services
Policies and Positions